{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:15:41Z","timestamp":1781932541300,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.orcp.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T03:08:44Z","timestamp":1686625724000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lipoxins and their relationship with inflammation-associated diseases. A systematic review"],"prefix":"10.1016","volume":"17","author":[{"given":"Maria Fernanda","family":"Serna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildrey","family":"Mosquera Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herney Andr\u00e9s","family":"Garc\u00eda-Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.orcp.2023.06.001_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.orcp.2023.06.001_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2015.03.083","article-title":"Lipoxins and aspirin-triggered lipoxins in resolution of inflammation","volume":"760","author":"Romano","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.orcp.2023.06.001_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mam.2017.02.003","article-title":"Specialized pro-resolving mediators in cardiovascular diseases","volume":"58","author":"Fredman","year":"2017","journal-title":"Mol Asp Med"},{"issue":"4","key":"10.1016\/j.orcp.2023.06.001_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.orcp.2023.06.001_bib5","first-page":"9","article-title":"Bioactive lipids and chronic inflammation: managing the fire within","author":"Chiurchi\u00f9","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.orcp.2023.06.001_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-019-00771-2","article-title":"Resolution of inflammation: from basic concepts to clinical application","volume":"41","author":"Neurath","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.orcp.2023.06.001_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/imcb.12206","article-title":"Efferocytosis: molecular mechanisms and pathophysiological perspectives","volume":"97","author":"Gheibi Hayat","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.orcp.2023.06.001_bib8","first-page":"181","article-title":"Lipoxins: nature\u2019s way to resolve inflammation","volume":"8","author":"Chandrasekharan","year":"2015","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.orcp.2023.06.001_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0090-6980(02)00047-3","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution","volume":"68\u201369","author":"Serhan","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"10.1016\/j.orcp.2023.06.001_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s10753-012-9567-x","article-title":"Effect of Lipoxin A4 on Myocardial Ischemia Reperfusion Injury Following Cardiac Arrest in a Rabbit Model","volume":"36","author":"Chen","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.orcp.2023.06.001_bib11","doi-asserted-by":"crossref","unstructured":"Petri M.H., Laguna-Fernandez A., Arnardottir H., Wheelock C.E., Perretti M., Hansson G.K., et al. Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E(-\/-) mice. Br J Pharmacol. 2017;174(22):4043\u201354.","DOI":"10.1111\/bph.13707"},{"issue":"11","key":"10.1016\/j.orcp.2023.06.001_bib12","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1096\/fj.10-159913","article-title":"FPR2\/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis","volume":"24","author":"Maderna","year":"2010","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.orcp.2023.06.001_bib13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1365-2222.2007.02806.x","article-title":"Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity","volume":"37","author":"\u00c7elik","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.orcp.2023.06.001_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-511X-10-76","article-title":"Lipoxins as biomarkers of lupus and other inflammatory conditions","volume":"10","author":"Das","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.orcp.2023.06.001_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mam.2017.04.006","article-title":"Pro-resolving mediators in the regulation of periodontal disease","volume":"58","author":"Van Dyke","year":"2017","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.orcp.2023.06.001_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3233\/JAD-141335","article-title":"Restoration of lipoxin A 4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model","volume":"43","author":"Dunn","year":"2015","journal-title":"J Alzheimer'S Dis"},{"key":"10.1016\/j.orcp.2023.06.001_bib17","doi-asserted-by":"crossref","unstructured":"Bonnans C., Vachier I., Chavis C., Godard P., Bousquet J., Chanez P. Lipoxins Are Potential Endogenous Antiinflammatory Mediators in Asthma2002. 1531\u20135 p.","DOI":"10.1164\/rccm.200201-053OC"},{"issue":"10","key":"10.1016\/j.orcp.2023.06.001_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ajh\/hpw053","article-title":"Lipoxin A4 is increased in the plasma of preeclamptic women","volume":"29","author":"Gomes","year":"2016","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.orcp.2023.06.001_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaci.2004.09.038","article-title":"Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound","volume":"115","author":"Vachier","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.orcp.2023.06.001_bib20","unstructured":"Liang S., Li X., Huang W., Gong H. Change of serum myeloperoxidase and lipoxin A4 level in coronary heart disease patients with anxiety and\/or depression2013. 370\u20135 p."},{"issue":"6","key":"10.1016\/j.orcp.2023.06.001_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/eci.12265","article-title":"Impaired resolution of inflammation in human chronic heart failure","volume":"44","author":"Reina-Couto","year":"2014","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.orcp.2023.06.001_bib22","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.orcp.2023.06.001_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/jre.12383","article-title":"Association between lipoxin A4 and interleukin-12 in gingival crevicular fluid: a preliminary investigation","volume":"52","author":"Tarannum","year":"2016","journal-title":"J Periodontal Res"},{"issue":"4","key":"10.1016\/j.orcp.2023.06.001_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.plefa.2012.08.003","article-title":"Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma","volume":"87","author":"Gil-Villa","year":"2012","journal-title":"Prostaglandins, Leukot Essent Fat Acids"},{"issue":"1","key":"10.1016\/j.orcp.2023.06.001_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer's disease","volume":"11","author":"Wang","year":"2015","journal-title":"Alzheimer'S Dement: J Alzheimer'S Assoc"},{"key":"10.1016\/j.orcp.2023.06.001_bib26","doi-asserted-by":"crossref","unstructured":"Yan C.-L., Zhang J., Hou Y. Decreased plasma Levels of lipoxin A4 in children with autism spectrum disorders2015.","DOI":"10.1097\/WNR.0000000000000350"},{"key":"10.1016\/j.orcp.2023.06.001_bib27","doi-asserted-by":"crossref","unstructured":"Yu D., Xu Z., Yin X., Zheng F., Lin X., Pan Q., et al. Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population. PloS one. 2015;10(11):e0142848-e.","DOI":"10.1371\/journal.pone.0142848"},{"issue":"10","key":"10.1016\/j.orcp.2023.06.001_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/jcpe.13173","article-title":"Salivary levels of specialized pro-resolving lipid mediators as indicators of periodontal health\/disease status","volume":"46","author":"Tob\u00f3n-Arroyave","year":"2019","journal-title":"J Clin Periodontol"},{"issue":"2","key":"10.1016\/j.orcp.2023.06.001_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5051\/jpis.2019.49.2.105","article-title":"The role of serum lipoxin A4 levels in the association between periodontal disease and metabolic syndrome","volume":"49","author":"Do\u011fan","year":"2019","journal-title":"J Periodontal Implant Sci"},{"issue":"1","key":"10.1016\/j.orcp.2023.06.001_bib30","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1038\/s41598-020-69831-0","article-title":"Lipoxins, RevD1 and 9, 13 HODE as the most important derivatives after an early incident of ischemic stroke","volume":"10","author":"Szczuko","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.orcp.2023.06.001_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","article-title":"Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?","volume":"177","author":"Serhan","year":"2010","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.orcp.2023.06.001_bib32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.orcp.2023.06.001_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1096\/fj.06-7227rev","article-title":"Resolution of inflammation: state of the art, definitions and terms","volume":"21","author":"Serhan","year":"2007","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.orcp.2023.06.001_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.58.3.4","article-title":"The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo","volume":"58","author":"Chiang","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.orcp.2023.06.001_bib35","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1096\/fj.02-0770com","article-title":"Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense","volume":"17","author":"Devchand","year":"2003","journal-title":"FASEB J"},{"issue":"15","key":"10.1016\/j.orcp.2023.06.001_bib36","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1111\/bph.12665","article-title":"Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7","volume":"171","author":"B\u00e4ck","year":"2014","journal-title":"Br J Pharm"},{"issue":"6","key":"10.1016\/j.orcp.2023.06.001_bib37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1164\/rccm.200801-061OC","article-title":"Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma","volume":"178","author":"Planagum\u00e0","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.orcp.2023.06.001_bib38","doi-asserted-by":"crossref","unstructured":"Pamplona F.A., Vit\u00f3ria G., Ribeiro F.C., Moraes C.A., Ledur P.F., Karmirian K., et al. Age-linked suppression of lipoxin A4 mediates cognitive deficits in mice and humans. bioRxiv. 2021:2021.11.12.468379.","DOI":"10.1101\/2021.11.12.468379"},{"issue":"7","key":"10.1016\/j.orcp.2023.06.001_bib39","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.exger.2005.04.004","article-title":"Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels","volume":"40","author":"Gangemi","year":"2005","journal-title":"Exp Gerontol"},{"issue":"4","key":"10.1016\/j.orcp.2023.06.001_bib40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/10641955.2014.931419","article-title":"Expression of lipoxin A4, TNF\u03b1 and IL-1\u03b2 in maternal peripheral blood, umbilical cord blood and placenta, and their significance in pre-eclampsia","volume":"33","author":"Dong","year":"2014","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"10.1016\/j.orcp.2023.06.001_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.12891\/ceog17902014","article-title":"Expression of anti-inflammatory mediator lipoxin A4 and inflammation responsive transcriptive factors NF-kappa B in patients with pre-eclampsia","volume":"41","author":"Huang","year":"2014","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.orcp.2023.06.001_bib42","first-page":"2792","article-title":"Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling","volume":"30","author":"Elajami","year":"2016","journal-title":"FASEB J Publ Fed Am Soc Exp Biol"},{"issue":"42","key":"10.1016\/j.orcp.2023.06.001_bib43","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers anti-inflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.orcp.2023.06.001_bib44","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.189.12.1923","article-title":"Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis","volume":"189","author":"Hachicha","year":"1999","journal-title":"J Exp Med"},{"issue":"20","key":"10.1016\/j.orcp.2023.06.001_bib45","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.202296999","article-title":"Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes","volume":"99","author":"J\u00f3zsef","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.orcp.2023.06.001_bib46","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.4049\/jimmunol.179.12.8533","article-title":"The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice","volume":"179","author":"Souza","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.orcp.2023.06.001_bib47","doi-asserted-by":"crossref","unstructured":"Xu Z., Zhao F., Lin F., Xiang H., Wang N., Ye D., et al. Pre-eclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator. Fertility and Sterility. 2014;102(1):282\u201390.e4.","DOI":"10.1016\/j.fertnstert.2014.03.056"},{"issue":"2","key":"10.1016\/j.orcp.2023.06.001_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/odi.13250","article-title":"Lipoxin suppresses inflammation via the TLR4\/MyD88\/NF-\u03baB pathway in periodontal ligament cells","volume":"26","author":"Ali","year":"2020","journal-title":"Oral Dis"},{"issue":"12","key":"10.1016\/j.orcp.2023.06.001_bib49","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2337\/db17-1317","article-title":"Lipoxins protect against inflammation in diabetes-associated atherosclerosis","volume":"67","author":"Brennan","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2023.06.001_bib50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.01.079","article-title":"Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion","volume":"1323","author":"Ye","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.orcp.2023.06.001_bib51","first-page":"13","article-title":"Formation, signaling and occurrence of specialized pro-resolving lipid mediators\u2014what is the evidence so far?","author":"Schebb","year":"2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.orcp.2023.06.001_bib52","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pcad.2014.07.007","article-title":"Cardiovascular disease in latin america: the growing epidemic","volume":"57","author":"Fernando","year":"2014","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X23000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X23000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:31:36Z","timestamp":1761730296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X23000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1871403X23000522"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2023.06.001","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoxins and their relationship with inflammation-associated diseases. A systematic review","name":"articletitle","label":"Article Title"},{"value":"Obesity Research & Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.orcp.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of Asia Oceania Association for the Study of Obesity.","name":"copyright","label":"Copyright"}]}}